Corin is a international orthopaedic implant company, leading the way in orthopaedic innovation. Its clinically-proven implants maximises healthcare value for patients, surgeons and healthcare providers. Find out how we’re supporting its geographic expansion and product development …
Corin
Why we backed them
- To back a market with strong growth characteristics driven by long-term trends such as ageing populations, active elderly people, obesity and growing need of revision implants
- To leverage its differentiated offering through implants, yielding best-in-class clinical outcomes and unique software proposition for surgeons
- To back a high-quality management team, led by CEO Stefano Alfonsi, who has a strong track record of delivering consistent double-digit organic growth and executing strategic acquisitions
The investment strategy
- To continue the transformation of Corin into an innovation leader in hardware and software, with best-in-class customer service, and presence in the most attractive orthopaedic markets
- To roll-out the product and technology offering in key geographies such as USA, Australia, Japan, UK and France
- To support strong volume growth through manufacturing scale-up
- To accelerate growth through M&A
The metrics
2018
Acquisition year
90%+
International sales
60,000+
Implants sold p.a.
$17.5bn
Market size